FGF23 and left ventricular hypertrophy in children with CKD

Mark M. Mitsnefes, Aisha Betoko, Michael F. Schneider, Isidro B. Salusky, Myles Selig Wolf, Harald Jüppner, Bradley A. Warady, Susan L. Furth, Anthony A. Portale

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Background and Objectives High plasma concentration of fibroblast growth factor 23 (FGF23) is a risk factor for left ventricular hypertrophy (LVH) in adults with CKD, and induces myocardial hypertrophy in experimental CKD. We hypothesized that high FGF23 levels associate with a higher prevalence of LVH in children with CKD. Design, setting, participants, & measurements We performed echocardiograms and measured plasma C-terminal FGF23 concentrations in 587 children with mild-to-moderate CKD enrolled in the Chronic Kidney Disease in Children (CKiD) study. We used linear and logistic regression to analyze the association of plasma FGF23 with left ventricular mass index (LVMI) and LVH (LVMI ≥ 95th percentile), adjusted for demographics, body mass index, eGFR, and CKD-specific factors. We also examined the relationship between FGF23 and LVH by eGFR level. Results Median age was 12 years (interquartile range, 8-15) and eGFR was 50 ml/min per 1.73 m2(interquartile range, 38-64). Overall prevalence of LVH was 11%. After adjustment for demographics and body mass index, the odds of having LVH was higher by 2.53 (95% confidence interval, 1.28 to 4.97; P<0.01) in participants with FGF23 concentrations ≥170 RU/ml compared with those with FGF23<100 RU/ml, but this association was attenuated after full adjustment. Among participants with eGFR≥45 ml/min per 1.73 m2, the prevalence of LVH was 5.4%, 11.2%, and 15.3% for those with FGF23 <100 RU/ml, 100-169 RU/ml, and ≥170 RU/ml, respectively (Ptrend=0.01). When eGFR was ≥45 ml/min per 1.73 m2, higher FGF23 concentrations were independently associated with LVH (fully adjusted odds ratio, 3.08 in the highest versus lowest FGF23 category; 95% confidence interval, 1.02 to 9.24; P<0.05; fully adjusted odds ratio, 2.02 per doubling of FGF23; 95% confidence interval, 1.29 to 3.17; P<0.01). By contrast, in participants with eGFR<45 ml/min per 1.73 m2, FGF23 did not associate with LVH. Conclusions Plasma FGF23 concentration ≥170 RU/ml is an independent predictor of LVH in children with eGFR≥45 ml/min per 1.73 m2.

Original languageEnglish (US)
Pages (from-to)45-52
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Issue number1
StatePublished - Jan 6 2018


  • Adult
  • Body mass index
  • Cardiovascular disease
  • Child
  • Children
  • Chronic
  • Chronic kidney disease
  • Confidence intervals
  • EGFR protein
  • Echocardiography
  • Epidermal growth factor
  • FGF23
  • Fibroblast growth factor 23
  • Fibroblast growth factors
  • Human
  • Humans
  • Hypertrophy
  • Left ventricular
  • Left ventricular hypertrophy
  • Logistic models
  • Odds ratio
  • Prevalence
  • Receptor
  • Renal insufficiency
  • Risk factors

ASJC Scopus subject areas

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation


Dive into the research topics of 'FGF23 and left ventricular hypertrophy in children with CKD'. Together they form a unique fingerprint.

Cite this